Journal
/
/
Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
Journal JoVE
Recherche en cancérologie
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Recherche en cancérologie
Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
DOI:

05:35 min

September 15, 2023

, , , , ,

Chapitres

  • 00:00Introduction
  • 00:38Plating of Ovarian Cancer Patient‐Derived Organoids for Viability Assay
  • 02:58Performing Viability Assay Using a Bioluminescence Plate Reader
  • 04:19Results: Effect of Platinum Chemotherapy on Ovarian Cancer Patient‐Derived Organoids
  • 05:17Conclusion

Summary

Traduction automatique

We present a protocol that can be used to conduct therapeutic drug testing with patient-derived ovarian cancer organoids.

Vidéos Connexes

Read Article